Relmada Therapeutics joins Jefferies Global Healthcare Conference fireside chat

RLMD•2026-11-04

Relmada Therapeutics will participate in the Jefferies Global Healthcare Conference in London from Nov. 16-19, 2026, with CEO Sergio Traversa and CFO Maged Shenouda scheduled for a fireside chat on Nov. 16 at noon GMT/7 a.m. ET.

1. Conference participation

Relmada Therapeutics will participate in the Jefferies Global Healthcare Conference in London from Nov. 16-19, 2026. CEO Sergio Traversa and CFO Maged Shenouda will hold a fireside chat on Nov. 16 at noon GMT/7 a.m. ET.

Relmada Therapeutics joins Jefferies Global Healthcare Conference fireside chat

1. Conference participation

Related News

Arrowhead Pharmaceuticals refinances $400 million loan with Sixth Street

Wedbush cuts Dynatrace target price to $50 from $54

Array Technologies beats Q3 revenue estimates; to merge with Shoals Technologies

Assurant raises 2026 adjusted EBITDA growth outlook to low-to-mid teens, excluding catastrophes

GlobalFoundries management commentary: US government share issuance contributes to Q3 2026 pretax loss